tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Bill Maughan, 10 are a BUY (62.5%), 6 are a HOLD (37.5%).
Analyst Bill Maughan, currently employed at CANACCORD, carries an average stock price target met ratio of 27.78% that have a potential upside of 2.79% achieved within 29 days.
Bill Maughan’s has documented 31 price targets and ratings displayed on 6 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on FATE, Fate Therapeutics at 10-May-2024.
Analyst best performing recommendations are on IMCR (IMMUNOCORE HOLDINGS LTD).
The best stock recommendation documented was for IMCR (IMMUNOCORE HOLDINGS LTD) at 2/29/2024. The price target of $63 was fulfilled within 8 days with a profit of $4.22 (6.28%) receiving and performance score of 7.85.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$22
$9.91 (81.97%)
$22
1 months 7 days ago
(11-Nov-2024)
0/10 (0%)
$11.82 (116.11%)
Buy
$21
$8.91 (73.70%)
$18
1 years 3 months 11 days ago
(07-Sep-2023)
0/5 (0%)
$16.4 (356.52%)
Buy
$13
$0.91 (7.53%)
$25
1 years 4 months 2 days ago
(16-Aug-2023)
1/4 (25%)
$7.59 (140.30%)
245
Buy
$20
$7.91 (65.43%)
1 years 4 months 2 days ago
(16-Aug-2023)
1/2 (50%)
$14.59 (269.69%)
36
Buy
$14
$1.91 (15.80%)
$17
2 years 27 days ago
(21-Nov-2022)
0/2 (0%)
$11.06 (376.19%)
What Year was the first public recommendation made by Bill Maughan?
